Allscripts Healthcare buy Royal Bank of Canada
Start price
19.01.24
/
50%
€8.20
Target price
19.01.25
€10.11
Performance (%)
-24.39%
Price
02.10.24
€7.80
Summary
This prediction is currently active. The prediction for Allscripts Healthcare disappoints with a performance of -24.39%. This prediction currently runs until 19.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Allscripts Healthcare | -2.500% | -2.500% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Allscripts Healthcare diskutieren
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Ratings data for MDRX provided by MarketBeat